Inventor · disambiguated record
Harpal S. Gill
Also filed as: GILL HARPAL · GILL HARPAL S
2 granted patents·8 pending applications·6 citations·filing 2002–2022
54Inventor score
Top patents by PatentIndex Score
10 records- 0175US2023190747A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2022·Application pending·0 cites
- 0274US7550469B2Heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2006·Granted Jun 23, 2009·3 cites·5 claims
- 0370US9469627B2Phenyloxadiazole derivatives as PGDS inhibitorsVANDEUSEN CHRISTOPHER L·Filed 2012·Granted Oct 18, 2016·3 cites·22 claims
- 0458US2021330671A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2021·Application pending·0 cites
- 0558US2019262338A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2018·Application pending·0 cites
- 0657US2020383982A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2019·Application pending·0 cites
- 0756US2019000845A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2018·Application pending·0 cites
- 0850US2005107389A1Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 0947US2010174088A1Process for the preparation of benzimidazol thienylamine compounds and derivatives thereof useful as sodium/proton exchanger type 3 inhibitorsSANOFI AVENTIS US LLC·Filed 2009·Application pending·0 cites
- 1043US2004030137A1Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →